Navigation Links
Sundia MediTech and Xcovery Announce Big Success in Drug Discovery
Date:2/10/2009

SHANGHAI, China, Feb. 10 /PRNewswire-Asia/ -- Sundia MediTech, a CRO company based in Shanghai, China and Xcovery, a company based in Florida, U.S.A. jointly announced their 2 year collaborative success in new drug discovery at IBC's BioProcess International Conference yesterday in San Diego, USA. So far their collaboration has achieved 4 pre-clinic candidates, with 2 more candidates to be identified within the next 3 months. Dr. Xiaochuan Wang, CEO of Sundia MediTech Company and Ms. Teri A. Swift, Vice President for Business Development of Xcovery, made the announcement together.

Both of Xcovery's founders are legendary figures in the U.S. biotech industry. Mr. Sherry Snyder, CEO of the company, is a pioneer and leader of this industry with significant contributions towards its development. In his professional career, he founded different companies including the well-known biotech company Genzyme. Company CSO Dr. Chris Liang earned his reputation as a leading drug discovery expert from his leadership and contribution to the discovery of Sutent, Pfizer's leading anti-cancer drug. In recent years, he continued to achieve multiple successes in drug discovery.

In 2006, Mr. Snyder invited Dr. Liang to start a new drug discovery company Xcovery. They abandoned the old model of using internal resources to do research and utilized almost 100% CRO resources for R&D work instead. After evaluating many CRO companies, amongst more than 10 in China they selected Sundia as their CRO service provider. "We are honored to have the opportunity of providing R&D service to Xcovery," said Sundia's CEO Dr. Xiaochuan Wang. "It is Sundia's objective to provide high end CRO service with rich R&D content to our clients. We have successfully identified 12 new pre-clinic candidates for our client companies from different countries."

According to Dr. Chris Liang, the result of Xcovery's collaboration with Sundia was much better than they expected. They got 4 (possibly 6) pre-clinic products in merely 2.5 years. Compared to their initial target, the research efficiency and outcome is ten folds higher. Mr. Snyder commented: "The value of this collaboration is not only in the pre-clinic candidates we've generated, but more importantly it sets a precedent as the most efficient and economical model for new drug discovery."

About the Companies:

Xcovery is a new biotechnology company spun out from The Scripps Research Institute by Sherry Snyder (CEO) and Chris Liang (CSO), with the support of several prominent academic partners. Xcovery develops next generation kinase therapeutics for cancer and inflammatory diseases more rapidly and economically than current approaches.

Sundia MediTech Company was founded in Shanghai in 2004 by a group of veterans of the US pharmaceutical industry to provide drug discovery and pharmaceutical development CRO services to clients worldwide. Over the past 5 years, Sundia has built a strong reputation as a leading CRO Company in China.


'/>"/>
SOURCE Sundia MediTech Company
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Sundia MediTech Ranked #16 in Deloitte Technology Fast 50 China
2. AMICAS Announces Integrations at More Than 100 MEDITECH Facilities
3. Weed Science Society of America Announces Winners in Annual Scientific Awards Program
4. Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals
5. Sagent Pharmaceuticals Announces Expansion of Cefazolin Product Line to Include Cefazolin for Injection, USP in 500mg Single-Dose Vial
6. LAB Research announces changes to its Board of Directors
7. SENOMYX ANNOUNCES INITIATION OF DEVELOPMENT ACTIVITIES FOR NEW BITTER BLOCKERS
8. PacificGMP and LigoCyte Pharmaceuticals Announce cGMP Manufacturing Collaboration
9. Diffusion Pharmaceuticals Announces Completion of a $2.9 Million Private Placement and Company Presentations at Upcoming Industry Conferences in Geneva, Switzerland and Naples, Florida
10. Stereotaxis Announces Fourth Quarter and Full Year 2008 Earnings Release Date and Conference Call
11. Amicus Therapeutics Announces Fourth Quarter and Full Year 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , Feb. 23, 2017 Aviva Systems ... announced the acquisition of GenWay Biotech Incorporated, a ... service and product offering for both the research ... facilitate growth and enhance capabilities for both entities. GenWay,s ... ELISA assays will nicely complement ASB,s objective to ...
(Date:2/23/2017)... UK (PRWEB) , ... February 22, 2017 , ... ... optics and photonics , have been named Fellows of the Society this year, ... technical contributions in the multidisciplinary fields of optics, photonics, and imaging as well ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... that is has acquired Kendall Research Systems, LLC (KRS) clinical development ... that develops neural interface technology for research and clinical applications. The terms of ...
(Date:2/22/2017)... Feb. 22, 2017  PrimeVax Immuno-Oncology, Inc. announced today ... at the Annual Biocom Global Life Science Partnering Conference.  ... 11:15 AM, at the Torrey Pines Lodge, in San ... organizers at Biocom who have chosen our company, amongst ... biotechnology companies, investors, and clinical researchers," said Mr. Chen. ...
Breaking Biology Technology:
(Date:2/3/2017)... 3, 2017  Texas Biomedical Research Institute announced that its ... Schlesinger as the Institute,s new President and CEO. Dr. ... 31, 2017. He is currently the Chair of the Department ... for Microbial Interface Biology at Ohio State University. ... President and CEO of Texas Biomed," said Dr. James ...
(Date:2/2/2017)... JACKSONVILLE, Fla. , Feb. 2, 2017 /PRNewswire/ ... ), a clinical-stage immuno-oncology company specializing in the ... vaccines for the treatment of cancer and metastatic ... multi-gram scale-up and GMP manufacturing of a second ... T-cell vaccine targeting folate receptor alpha. The manufactured ...
(Date:2/2/2017)... , Feb. 1, 2017  Central to ... and meaningful advances worldwide, The Japan Prize Foundation ... Prize, who have pushed the envelope in their ... and Communication. Three scientists are being recognized with ... achievements that not only contribute to the advancement ...
Breaking Biology News(10 mins):